The global genomics market is undergoing a seismic shift. Once confined to high-end academic research centers, DNA sequencing platforms are now becoming localized in community hospitals, agricultural research hubs, and forensic laboratories. As a leading exporter from China, we have witnessed the transformation from "expensive niche technology" to "essential diagnostic tool."
Real-time sequencing allows for personalized cancer therapies and rapid identification of rare genetic disorders, driving massive demand in Europe and North America.
Developing nations are increasingly adopting DNA sequencing to enhance crop resilience and livestock health, ensuring food security in the face of climate change.
The recent global health events have accelerated the need for decentralized nucleic acid extraction and sequencing to track viral mutations instantly.
As the "World's Factory" evolves into the "World's High-Tech Hub," China’s biotechnology sector offers unparalleled advantages for global B2B procurement:
From magnetic bead reagents to high-throughput automated sequencing library preparation systems, our factory controls the entire supply chain, ensuring cost-efficiency and consistent quality.
The speed at which Chinese biotech firms iterate on hardware is unmatched. Our Eosbot Seq24 and BNP series represent the cutting edge of automated nucleic acid processing.
Whether you need a single unit for a private lab or a hundred units for a national health initiative, our manufacturing capacity scales to meet the procurement needs of global distributors.
Ningbo Medvok Medical Co., Ltd. is a high-tech biotechnology company focused on the R&D and production of antigens, antibodies and downstream detection reagents for diagnosis and therapy. The product pipelines cover cardiovascular and cerebrovascular, inflammation, infectious diseases, tumors, hormones and other categories, from raw materials to finished products.
Innovation is in our DNA! Bioantibody keeps developing new technologies. Currently, our products have been delivered to more than 60 countries and cities worldwide. Using the ISO 13485 management system, the product quality is greatly trusted by customers. With the mission "Biotech For A Better Life", we are committed to innovation and providing our best solutions to our customers. We sincerely believe we could make our special contribution to human ecology and health.
As an IVD solutions provider, we have worked and will keep working intensively to support research and foment knowledge and prevention of the diseases. For us, a well-informed society is a healthier society. We care about protecting the human health and hope all of society to have access to clean, affordable, and reliable biotechnologies. Furthermore, our economic development will be compatible with proper conduct in relation to ethics, society, the workplace, the environment and respect for human rights.
Our DNA sequencing and nucleic acid extraction platforms are designed for versatility across multiple localized environments:
Automated systems like the BNP96 Nucleic Acid Extractor are critical for high-throughput patient testing. They reduce human error, minimize contamination risk, and provide rapid results for infectious disease screening.
Precision is paramount in forensics. Our horizontal electrophoresis systems and fluorescence PCR systems provide the high sensitivity required for DNA profiling and evidence analysis.
Portable QPCR systems enable field-testing for veterinary health, such as detecting outbreaks in livestock directly on the farm, preventing economic losses and zoonotic transmission.
For international buyers and procurement officers, selecting the right exporter is a balance of technical specification and logistical reliability. The China DNA sequencing platforms exporter landscape offers several key features that global markets demand:
The future of genomics is decentralized and automated. By partnering with a proven Chinese factory, global health organizations and private laboratories can stay ahead of the curve, utilizing AI-ready sequencing systems and high-throughput extraction technologies to improve human health outcomes globally.